Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 38% ± 23% | |
intestine | 9 studies | 37% ± 22% | |
kidney | 6 studies | 33% ± 18% | |
eye | 6 studies | 39% ± 16% | |
uterus | 6 studies | 33% ± 21% | |
pancreas | 5 studies | 27% ± 7% | |
brain | 5 studies | 37% ± 11% | |
placenta | 4 studies | 24% ± 8% | |
prostate | 4 studies | 20% ± 4% | |
breast | 4 studies | 37% ± 9% | |
ovary | 3 studies | 37% ± 12% | |
skin | 3 studies | 27% ± 6% | |
thymus | 3 studies | 67% ± 25% | |
bone marrow | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3885.39 | 459 / 459 | 99% | 175.29 | 1108 / 1118 |
prostate | 100% | 2740.96 | 245 / 245 | 99% | 94.24 | 496 / 502 |
lung | 100% | 3236.34 | 576 / 578 | 99% | 156.51 | 1139 / 1155 |
ovary | 100% | 9283.14 | 180 / 180 | 98% | 146.95 | 422 / 430 |
intestine | 100% | 1664.35 | 964 / 966 | 98% | 109.08 | 514 / 527 |
stomach | 100% | 2236.31 | 359 / 359 | 97% | 117.81 | 278 / 286 |
bladder | 100% | 2154.62 | 21 / 21 | 96% | 157.57 | 486 / 504 |
esophagus | 99% | 1100.49 | 1430 / 1445 | 96% | 128.84 | 175 / 183 |
uterus | 100% | 5449.45 | 170 / 170 | 94% | 129.62 | 430 / 459 |
pancreas | 98% | 1813.40 | 323 / 328 | 94% | 92.24 | 167 / 178 |
thymus | 100% | 2278.39 | 652 / 653 | 92% | 118.26 | 559 / 605 |
kidney | 100% | 2339.99 | 89 / 89 | 84% | 72.91 | 753 / 901 |
skin | 99% | 2117.69 | 1796 / 1809 | 83% | 86.19 | 394 / 472 |
brain | 90% | 817.94 | 2372 / 2642 | 92% | 180.20 | 647 / 705 |
adrenal gland | 96% | 733.17 | 247 / 258 | 41% | 19.11 | 94 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 98.88 | 1 / 1 |
adipose | 100% | 2693.75 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1538.79 | 1318 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 874.45 | 237 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 86.01 | 38 / 45 |
heart | 83% | 767.70 | 715 / 861 | 0% | 0 | 0 / 0 |
liver | 35% | 392.02 | 80 / 226 | 31% | 28.90 | 125 / 406 |
eye | 0% | 0 | 0 / 0 | 61% | 40.10 | 49 / 80 |
peripheral blood | 29% | 521.10 | 266 / 929 | 0% | 0 | 0 / 0 |
muscle | 26% | 159.99 | 211 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 11.09 | 6 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0021782 | Biological process | glial cell development |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0035910 | Biological process | ascending aorta morphogenesis |
GO_2000761 | Biological process | positive regulation of N-terminal peptidyl-lysine acetylation |
GO_0021510 | Biological process | spinal cord development |
GO_0048485 | Biological process | sympathetic nervous system development |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0007507 | Biological process | heart development |
GO_0043516 | Biological process | regulation of DNA damage response, signal transduction by p53 class mediator |
GO_0048593 | Biological process | camera-type eye morphogenesis |
GO_0003183 | Biological process | mitral valve morphogenesis |
GO_0045662 | Biological process | negative regulation of myoblast differentiation |
GO_0045663 | Biological process | positive regulation of myoblast differentiation |
GO_0045588 | Biological process | positive regulation of gamma-delta T cell differentiation |
GO_0003357 | Biological process | noradrenergic neuron differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0003215 | Biological process | cardiac right ventricle morphogenesis |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0061484 | Biological process | hematopoietic stem cell homeostasis |
GO_0031647 | Biological process | regulation of protein stability |
GO_0030217 | Biological process | T cell differentiation |
GO_0030182 | Biological process | neuron differentiation |
GO_0060485 | Biological process | mesenchyme development |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0060563 | Biological process | neuroepithelial cell differentiation |
GO_0050821 | Biological process | protein stabilization |
GO_0001666 | Biological process | response to hypoxia |
GO_0002328 | Biological process | pro-B cell differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0045727 | Biological process | positive regulation of translation |
GO_0007420 | Biological process | brain development |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0031018 | Biological process | endocrine pancreas development |
GO_0010467 | Biological process | gene expression |
GO_0060993 | Biological process | kidney morphogenesis |
GO_0003289 | Biological process | atrial septum primum morphogenesis |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0007399 | Biological process | nervous system development |
GO_0014009 | Biological process | glial cell proliferation |
GO_0042593 | Biological process | glucose homeostasis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035019 | Biological process | somatic stem cell population maintenance |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0035198 | Molecular function | miRNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SOX4 |
Protein name | Transcription factor SOX-4 |
Synonyms | |
Description | FUNCTION: Transcriptional activator that binds with high affinity to the T-cell enhancer motif 5'-AACAAAG-3' motif . Required for IL17A-producing Vgamma2-positive gamma-delta T-cell maturation and development, via binding to regulator loci of RORC to modulate expression (By similarity). Involved in skeletal myoblast differentiation by promoting gene expression of CALD1 . . |
Accessions | Q06945 ENST00000244745.4 |